Clinical Trial Update: Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of transcatheter arterial chemoembolization (TACE) and sorafenib for hepatocellular carcinoma, including unresectable…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Kindai University | Conditions: Hepatocellular Carcinoma, Unresectable Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN